Allarity Therapeutics Inc(ALLR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALLR Allarity Therapeutics Inc

交易中 02-03 15:43:32 EST

0.8821

-0.0820

-8.51%

最高0.9600	最低0.7688	成交量65.74万
今开0.9600	昨收0.9641	日振幅19.83%
总市值1,395万	流通市值1,393万	总股本1,581万
成交额56.67万	换手率4.16%	流通股本1,579万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALLR","market":"US","secType":"STK","nameCN":"Allarity Therapeutics Inc","latestPrice":0.8821,"timestamp":1770151236021,"preClose":0.9641,"halted":0,"volume":657418,"delay":0,"changeRate":-0.08505341769525979,"floatShares":15787000,"shares":15811900,"eps":-1.334837,"marketStatus":"交易中","change":-0.082,"latestTime":"02-03 15:43:32 EST","open":0.96,"high":0.96,"low":0.7688,"amount":566684.7176972,"amplitude":0.19832,"askPrice":0.8985,"askSize":100,"bidPrice":0.882,"bidSize":870,"shortable":0,"etf":0,"ttmEps":-1.334837,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770152400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.9641,"preHourTrading":{"tag":"盘前","latestPrice":0.98,"preClose":0.9641,"latestTime":"09:25 EST","volume":13731,"amount":13702.3818498,"timestamp":1770128700158,"change":0.0159,"changeRate":0.016492,"amplitude":0.020641},"postHourTrading":{"tag":"盘后","latestPrice":0.9902,"preClose":0.9641,"latestTime":"19:58 EST","volume":29314,"amount":28056.284,"timestamp":1770080310955,"change":0.0261,"changeRate":0.027072,"amplitude":0.06213},"volumeRatio":3.089208},"requestUrl":"/m/hq/s/ALLR","defaultTab":"news","newsList":[{"id":"1114870357","title":"Allarity Therapeutics与美国退伍军人事务部合作开展Stenoparib联合替莫唑胺治疗复发性小细胞肺癌的II期临床试验现开放入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1114870357","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114870357?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:03","pubTimestamp":1770123805,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics宣布，其与美国退伍军人事务部合作开展的II期临床试验现已开放患者入组。该试验旨在评估Stenoparib与替莫唑胺联合疗法治疗复发性小细胞肺癌的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"1126939874","title":"Allarity Therapeutics Inc于1月28日与Tumim Stone Capital签署股票购买协议——美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1126939874","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126939874?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:51","pubTimestamp":1769691076,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，生物制药公司Allarity Therapeutics Inc（简称：ALLR）于1月28日与投资机构Tumim Stone Capital正式达成一项股票购买协议。该协议的签署标志着双方资本合作进入实质性阶段，为Allarity Therapeutics Inc的后续研发及业务拓展提供了资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2577874754","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577874754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577874754?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:56","pubTimestamp":1761054963,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时56分，Allarity Therapeutics, Inc.股票出现波动，股价快速下挫5.30%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1171.46%、160.87%、45.13%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为215.34%、78.99%、47.03%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc 是一家临床阶段的精准医学制药公司，专注于为医疗需求未得到满足的患者开发新型的抗癌疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021215603973ac60c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021215603973ac60c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","BK4139","ALLR"],"gpt_icon":0},{"id":"1146787242","title":"Allarity Therapeutics Inc：接受Stenoparib/2X-121每日两次治疗的卵巢癌患者中位总生存期超过25个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1146787242","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146787242?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:05","pubTimestamp":1758542713,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc宣布，接受Stenoparib/2X-121每日两次治疗的卵巢癌患者中位总生存期超过25个月。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"1178988843","title":"Allarity Therapeutics获得FDA快速通道认定 用于Stenoparib治疗晚期卵巢癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1178988843","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178988843?lang=zh_cn&edition=full","pubTime":"2025-08-26 20:01","pubTimestamp":1756209676,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc已获得美国食品药品监督管理局(FDA)的快速通道认定，该认定适用于其药物Stenoparib用于治疗晚期卵巢癌。这一认定将有助于加速该药物的开发和审批流程，为晚期卵巢癌患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"gpt_icon":0},{"id":"2518627342","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518627342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518627342?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613547,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Allarity Therapeutics, Inc.股票出现波动，股价大幅拉升5.66%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2025.42%、400.50%、57.02%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、珐博进，振幅分别为99.13%、98.72%、98.49%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213227abf2fc69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213227abf2fc69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","BK4139","LENZ"],"gpt_icon":0},{"id":"2517146166","title":"Allarity Therapeutics, Inc.盘中异动 快速下挫5.56%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517146166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517146166?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271534,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Allarity Therapeutics, Inc.股票出现波动，股价大幅下挫5.56%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为954.38%、104.36%、49.04%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223214abeb77ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223214abeb77ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALLR"],"gpt_icon":0},{"id":"2514856824","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨12.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856824?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:33","pubTimestamp":1740580384,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时33分，Allarity Therapeutics, Inc.股票出现异动，股价急速上涨12.06%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Nutriband Inc C/Wts 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2950.93%、121.39%、91.44%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为78.81%、16.86%、14.35%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223304abdded46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223304abdded46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","LENZ","BK4139"],"gpt_icon":0},{"id":"2513727011","title":"Allarity Therapeutics, Inc.盘中异动 大幅下跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727011?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:49","pubTimestamp":1740408549,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时49分，Allarity Therapeutics, Inc.股票出现波动，股价大幅跳水5.61%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为123.29%、53.08%、24.85%，振幅较大的相关个股有Pepgen Inc.、Vaxart, Inc. - Common Stock、Immunic, Inc.，振幅分别为137.23%、21.42%、20.47%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242249109890fa29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242249109890fa29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALLR"],"gpt_icon":0},{"id":"2512957160","title":"Allarity Therapeutics, Inc.盘中异动 股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512957160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512957160?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:03","pubTimestamp":1739898189,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时03分，Allarity Therapeutics, Inc.股票出现波动，股价快速拉升5.30%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Aditxt, Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为461.97%、183.70%、154.75%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010309a24acd65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010309a24acd65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","BK4139","LENZ"],"gpt_icon":0},{"id":"2510386063","title":"Allarity Therapeutics, Inc.盘中异动 早盘急速下挫5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510386063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510386063?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:57","pubTimestamp":1739285856,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时57分，Allarity Therapeutics, Inc.股票出现波动，股价大幅下挫5.71%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.26%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2422.03%、672.10%、303.16%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical, Inc.，振幅分别为45.29%、37.99%、33.04%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225736abcb0bee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225736abcb0bee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALLR"],"gpt_icon":0},{"id":"2509740932","title":"Allarity Therapeutics, Inc.盘中异动 大幅跳水5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509740932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509740932?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852336,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时32分，Allarity Therapeutics, Inc.股票出现波动，股价快速跳水5.71%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immatics N V C/Wts 01/07/2025 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3890.21%、340.23%、114.95%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Rani Therapeutics Holdings, Inc.、Relmada Therapeutics, Inc.，振幅分别为33.33%、15.97%、14.26%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223216abc4d4a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223216abc4d4a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","BK4139","LENZ"],"gpt_icon":0},{"id":"2506730810","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨8.82%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506730810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506730810?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:33","pubTimestamp":1737988438,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时33分，Allarity Therapeutics, Inc.股票出现波动，股价急速拉升8.82%。截至发稿，该股报1.48美元/股，成交量45.2735万股，换手率10.21%，振幅3.68%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为730.99%、44.39%、40.37%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Evaxion Biotech As，振幅分别为53.75%、28.15%、18.91%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223359a2316b9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223359a2316b9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALLR"],"gpt_icon":0},{"id":"2505866102","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨6.06%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505866102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505866102?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:36","pubTimestamp":1737729376,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时36分，Allarity Therapeutics, Inc.股票出现波动，股价大幅上涨6.06%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Pmgc Holdings Inc.、Evaxion Biotech As、Transcode Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为2095.25%、1274.89%、847.54%，振幅较大的相关个股有Pmgc Holdings Inc.、Evaxion Biotech As、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为40.91%、35.16%、24.58%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223616a22e5b26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223616a22e5b26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","LENZ","BK4139"],"gpt_icon":0},{"id":"2501758057","title":"Allarity Therapeutics, Inc.盘中异动 股价大跌6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501758057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501758057?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:41","pubTimestamp":1736347278,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时41分，Allarity Therapeutics, Inc.股票出现异动，股价快速下挫6.41%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1530.28%、535.88%、508.34%，振幅较大的相关个股有Silo Pharma, Inc.、Sana Biotechnology, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为135.78%、84.85%、68.53%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822411895fd00c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822411895fd00c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLR","BK4139"],"gpt_icon":0},{"id":"2501584612","title":"Allarity Therapeutics, Inc.盘中异动 早盘快速跳水5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501584612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501584612?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:47","pubTimestamp":1736174837,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时47分，Allarity Therapeutics, Inc.股票出现异动，股价快速下挫5.66%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Cns Pharmaceuticals, Inc.、Cytomed Therapeutics Limited、Aditxt, Inc.较为活跃，换手率分别为246.32%、84.40%、64.56%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为39.34%、36.72%、36.57%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622471895fa7601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622471895fa7601&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","LENZ","BK4139"],"gpt_icon":0},{"id":"2495615293","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495615293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495615293?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:31","pubTimestamp":1735655494,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时31分，Allarity Therapeutics, Inc.股票出现异动，股价急速拉升7.14%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，知临集团、Onconetix, Inc.、Eyenovia, Inc.涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为876.93%、637.79%、132.85%，振幅较大的相关个股有知临集团、Onconetix, Inc.、Eyenovia, Inc.，振幅分别为54.61%、48.05%、18.27%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231223135ab99820e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231223135ab99820e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLR","LENZ"],"gpt_icon":0},{"id":"2495523495","title":"Allarity Therapeutics, Inc.盘中异动 早盘大幅跳水5.56%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495523495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495523495?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:34","pubTimestamp":1735569244,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时34分，Allarity Therapeutics, Inc.股票出现异动，股价快速下挫5.56%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vincerx Pharma, Inc.、Polyrizon Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Polyrizon Ltd.、Vincerx Pharma, Inc.较为活跃，换手率分别为687.81%、327.60%、94.86%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Quoin Pharmaceuticals Ltd、Nextcure, Inc.，振幅分别为192.98%、118.04%、113.29%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123022340495f2c345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123022340495f2c345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","BK4139","LENZ"],"gpt_icon":0},{"id":"2492182151","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大跌5.45%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492182151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492182151?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:52","pubTimestamp":1734533534,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时52分，Allarity Therapeutics, Inc.股票出现波动，股价急速下跌5.45%。截至发稿，该股报1.04美元/股，成交量5.3149万股，换手率1.20%，振幅6.36%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1657.50%、361.21%、271.18%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为227.62%、92.48%、66.83%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218225214984cb303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218225214984cb303&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLR","BK4139"],"gpt_icon":0},{"id":"2485497590","title":"Allarity Therapeutics, Inc.盘中异动 早盘急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497590?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:38","pubTimestamp":1732199898,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时38分，Allarity Therapeutics, Inc.股票出现波动，股价快速拉升5.04%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Conduit Pharmaceuticals Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Biodexa Pharmaceuticals Plc、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为243.86%、57.36%、43.98%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.00%、66.75%、39.02%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122381898e43ed9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122381898e43ed9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allarity.com","stockEarnings":[{"period":"1week","weight":-0.1898},{"period":"1month","weight":-0.1543},{"period":"3month","weight":-0.2162},{"period":"6month","weight":-0.0454},{"period":"1year","weight":-0.1392},{"period":"ytd","weight":-0.1073}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0179},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.099},{"period":"1year","weight":0.1555},{"period":"ytd","weight":0.0198}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allarity Therapeutics, Inc.于2021年4月6日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，通过以精准医学方法开发差异化的新型治疗候选药物及其专有的DRP伴随诊断，来满足肿瘤学中一些最大的未满足需求。该公司使用其专有的DRP预测生物标志物平台选择他们认为对其治疗候选药物反应最灵敏的患者。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.137955},{"month":2,"riseRate":0,"avgChangeRate":-0.235095},{"month":3,"riseRate":0.25,"avgChangeRate":-0.326601},{"month":4,"riseRate":0.25,"avgChangeRate":-0.371644},{"month":5,"riseRate":0.25,"avgChangeRate":-0.092052},{"month":6,"riseRate":0.25,"avgChangeRate":-0.349039},{"month":7,"riseRate":0.25,"avgChangeRate":-0.205374},{"month":8,"riseRate":0.25,"avgChangeRate":0.045342},{"month":9,"riseRate":0.25,"avgChangeRate":-0.31064},{"month":10,"riseRate":0,"avgChangeRate":-0.290985},{"month":11,"riseRate":0,"avgChangeRate":-0.125579},{"month":12,"riseRate":0.25,"avgChangeRate":-0.118424}],"exchange":"NASDAQ","name":"Allarity Therapeutics Inc","nameEN":"Allarity Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allarity Therapeutics Inc(ALLR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allarity Therapeutics Inc(ALLR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allarity Therapeutics Inc,ALLR,Allarity Therapeutics Inc股票,Allarity Therapeutics Inc股票老虎,Allarity Therapeutics Inc股票老虎国际,Allarity Therapeutics Inc行情,Allarity Therapeutics Inc股票行情,Allarity Therapeutics Inc股价,Allarity Therapeutics Inc股市,Allarity Therapeutics Inc股票价格,Allarity Therapeutics Inc股票交易,Allarity Therapeutics Inc股票购买,Allarity Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allarity Therapeutics Inc(ALLR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allarity Therapeutics Inc(ALLR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}